4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-21-078411
Director sold 15,827 shares at an average $19.30 ($305,449)
- Director acquired 15,827 shares (option exercise)
- Director acquired 6,019 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Howard Director | 2021-06-07 | Option exercise | +7,827 | $16.43 | $128,598 | 140,741 | D |
| Lee Howard Director | 2021-06-07 | Sale | −7,827 | $19.28 | $150,941 | 132,914 | D |
| Lee Howard Director | 2021-06-07 | Grant or award | +6,019 | 138,933 | D | ||
| Lee Howard Director | 2021-06-08 | Option exercise | +8,000 | $16.43 | $131,440 | 146,933 | D |
| Lee Howard Director | 2021-06-08 | Sale | −8,000 | $19.31 | $154,508 | 138,933 | D |
| Derivatives | |||||||
| Lee Howard Director | 2021-06-07 | Returned to the company · Stock Option (right to buy) | −7,827 | 8,000 | D | ||
| Lee Howard Director | 2021-06-07 | Grant or award · Stock Option (right to buy) | +17,182 | 17,182 | D | ||
| Lee Howard Director | 2021-06-08 | Returned to the company · Stock Option (right to buy) | −8,000 | 0 | D | ||
| Open-market sales · 15,827 sh · avg $19.30 · $305,449 | |||||||
Loading xslF345X03/tm2119150-6_4seq1.xml…